TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive ASH Highlights: Improved Treatments For NHL, Poor Prognostic Factors For B-Cell In Children January 30, 2004